Territory Business Manager
CurrentBiotech start up with first commercial launch December 2021. Launched an infusion, Vyvgart, for Myasthenia Gravis, a rare Neuromuscular Disease. Field experience with Specialty Pharmacy, Buy & Bill medical benefits, HUB delivery model and complex cross functional team. Launched Vyvgart IV formulation in 2022 top 10% Nationally and 312.5% to goal. Launched.